Low density lipoproteins of male donors decrease prostacyclin (PGI2) and enhance thromboxane (TXA2) release from rat aortas perfused under pulsatile pressure. 1985

J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster

The influence of low density lipoproteins (LDL)-cholesterol (1.69 +/- 0.08 mg/ml) and of high density lipoproteins (HDL)-cholesterol (0.62 +/- 0.09 mg/ml), respectively, on the levels of 6-oxo-PGF1 alpha and TXB2 in the perfusates of rat aortas perfused under pulsatile pressure was studied. After passage through the aortas the concentration of LDL-cholesterol was significantly decreased in the perfusates, whereas the HDL-cholesterol level was unchanged. In comparison to controls, perfused with lipoprotein free solution, the concentration of 6-oxo-PGF1 alpha was significantly decreased more than 50% by LDL and the TXB2 level was enhanced significantly by approximately 50%. This results in a significant rise of the TXB2/6-oxo-PGF1 alpha ratio in the perfusates. HDL did not significantly change the ratio of these eicosanoids in the perfusates. These results suggest that this concentration of LDL enhanced the formation of the proaggregatory TXA2 and decreased the formation of the antiaggregatory PGI2 in rat aortas perfused under pulsatile pressure. The proaggregatory action of an elevated level of LDL during the development of atherosclerosis in men may be also mediated by changes in the metabolism of eicosanoids of the vessel wall.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood

Related Publications

J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster
August 1986, Prostaglandins, leukotrienes, and medicine,
J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster
January 1978, Acta biologica et medica Germanica,
J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster
August 1985, European journal of radiology,
J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster
August 1990, Thrombosis research,
J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster
February 1991, Zhonghua nei ke za zhi,
J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster
November 1999, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster
May 1991, Prostaglandins, leukotrienes, and essential fatty acids,
J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster
December 1979, Biochemical pharmacology,
J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster
March 1985, Research communications in chemical pathology and pharmacology,
J Beitz, and P Hoffmann, and C Taube, and A Beitz, and W Förster
January 1980, Artery,
Copied contents to your clipboard!